Clinical Trial Update: Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating recombinant human endostatin in combination with the mFOLFOX6 regimen for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Recombinant human endostatin (recombinant human endostatin)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Neoplasm | Phase 1 | Status: UNKNOWN